Application
Western blot analysis of DFFA Antibody (C-term) in K562 cell line lysates (35ug/lane). DFFA (arrow) was detected using the purified Pab.Application
Western blot analysis of DFFA (arrow) using rabbit polyclonal DFFA Antibody (C-term) . 293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected (Lane 2) with the DFFA gene.| Product Name | DFFA Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | DFFA; DFF1; DFF45; DNA fragmentation factor subunit alpha; DNA fragmentation factor 45 kDa subunit; Inhibitor of CAD |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | DFF1 DFF45 |
|---|---|
| Alternative Names | DFFA DFF1 DFF45 DNA fragmentation factor subunit alpha DNA fragmentation factor 45 kDa subunit Inhibitor of CAD |
| Molecular Weight(MW) | 36522 Da |
| Function | Inhibitor of the caspase-activated DNase (DFF40). |
| Tissue Specificity | This DFFA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 302~331 amino acids from the C-terminal region of human DFFA. |
| Cellular Localization | Cytoplasm. |
| Entrez Gene | 1676 |
|---|
Application
Western blot analysis of DFFA Antibody (C-term) in K562 cell line lysates (35ug/lane). DFFA (arrow) was detected using the purified Pab.
Application
Western blot analysis of DFFA (arrow) using rabbit polyclonal DFFA Antibody (C-term) . 293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected (Lane 2) with the DFFA gene.| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
